Susquehanna International Group’s Hepion Pharmaceuticals HEPA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-521
| Closed | -$12.2K | – | 6688 |
|
|
2024
Q4 | $12.2K | Buy |
521
+228
| +78% | +$5.36K | ﹤0.01% | 6033 |
|
|
2024
Q3 | $9.81K | Hold |
293
| – | – | ﹤0.01% | 5467 |
|
|
2024
Q2 | $15.8K | Hold |
293
| – | – | ﹤0.01% | 5431 |
|
|
2024
Q1 | $36.4K | Hold |
293
| – | – | ﹤0.01% | 5211 |
|
|
2023
Q4 | $47.9K | Hold |
293
| – | – | ﹤0.01% | 5551 |
|
|
2023
Q3 | $73K | Hold |
293
| – | – | ﹤0.01% | 5022 |
|
|
2023
Q2 | $154K | Buy |
293
+138
| +89% | +$72.6K | ﹤0.01% | 4793 |
|
|
2023
Q1 | $120K | Buy |
155
+59
| +61% | +$45.7K | ﹤0.01% | 5164 |
|
|
2022
Q4 | $28.8K | Sell |
96
-69
| -42% | -$20.7K | ﹤0.01% | 5286 |
|
|
2022
Q3 | $84K | Buy |
165
+71
| +76% | +$36.1K | ﹤0.01% | 5340 |
|
|
2022
Q2 | $54K | Buy |
94
+45
| +92% | +$25.9K | ﹤0.01% | 5217 |
|
|
2022
Q1 | $64K | Sell |
49
-40
| -45% | -$52.2K | ﹤0.01% | 5253 |
|
|
2021
Q4 | $101K | Sell |
89
-26
| -23% | -$29.5K | ﹤0.01% | 5291 |
|
|
2021
Q3 | $176K | Sell |
115
-123
| -52% | -$188K | ﹤0.01% | 4769 |
|
|
2021
Q2 | $472K | Sell |
238
-116
| -33% | -$230K | ﹤0.01% | 3961 |
|
|
2021
Q1 | $651K | Buy |
354
+314
| +785% | +$577K | ﹤0.01% | 3533 |
|
|
2020
Q4 | $88K | Buy |
+40
| New | +$88K | ﹤0.01% | 4524 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4641 |
|
|
2019
Q3 | – | Sell |
-11
| Closed | -$44K | – | 4669 |
|
|
2019
Q2 | $44K | Buy |
+11
| New | +$44K | ﹤0.01% | 4284 |
|
|
2018
Q1 | – | Hold |
0
| – | -$8K | – | 3841 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 3580 |
|